{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:42:01Z","timestamp":1787892121530,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["643736"],"award-info":[{"award-number":["643736"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40273-022-01193-z","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T04:02:44Z","timestamp":1665633764000},"page":"1235-1246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficiency of the EmERGE Pathway of Care in Five European HIV Centres"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9675-8921","authenticated-orcid":false,"given":"Eduard J.","family":"Beck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundhiya","family":"Mandalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Platon","family":"Yfantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie J.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wittevogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Apers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Benkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sime","family":"Zekan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josip","family":"Begovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana S.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Teofilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goncalo","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida D. F.","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Fatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Whetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EmERGE Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"issue":"1","key":"1193_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/healthcare9010058","volume":"9","author":"D Giansanti","year":"2021","unstructured":"Giansanti D. The role of the mHealth in the fight against the Covid-19: successes and failures. Healthcare (Basel). 2021;9(1):58.\u00a0https:\/\/www.mdpi.com\/2227-9032\/9\/1\/58 Accessed 15 Apr 2022","journal-title":"Healthcare (Basel)."},{"key":"1193_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13643-018-0921-4","volume":"8","author":"D Taylor","year":"2019","unstructured":"Taylor D, Lunny C, Loli P, Warje O, Geldman J, Wong T, et al. Effectiveness of text messaging interventions on prevention, detection, treatment, and knowledge outcomes for sexually transmitted infections (STIs)\/HIV: a systematic review and meta-analysis. Syst Rev. 2019;8:12.\u00a0 \u00a0\u00a0https:\/\/doi.org\/10.1186\/s13643-018-0921-4 Accessed 15 Apr 2022","journal-title":"Syst Rev"},{"key":"1193_CR3","doi-asserted-by":"crossref","unstructured":"Cooper V, Clatworthy J, Whetham J, EmERGE Consortium. mHealth interventions to support self-management in HIV: a systematic review. Open AIDS J. 2017;11:119\u201332.    https:\/\/openaidsjournal.com\/VOLUME\/11\/PAGE\/119\/ Accessed 15 Apr 2022","DOI":"10.2174\/1874613601711010119"},{"key":"1193_CR4","doi-asserted-by":"crossref","unstructured":"Chidambaram S, Erridge S, James Kinross J, Purkayastha S, on behalf of the PanSurg Collaborative. Observational study of UK mobile health apps for COVID-19. Lancet Digital Health. 2020;2:e388\u201390.  https:\/\/www.thelancet.com\/journals\/landig\/article\/PIIS2589-7500(20)30144-8\/fulltext Accessed 15 Apr 2022","DOI":"10.1016\/S2589-7500(20)30144-8"},{"key":"1193_CR5","unstructured":"Cheney C. How to use telehealth in cancer care during the coronavirus pandemic and beyond. HealthLeaders, May 19, 2020. https:\/\/www.healthleadersmedia.com\/clinical-care\/how-use-telehealth-cancer-care-during-coronavirus-pandemic-and-beyond. Accessed 15 Apr 2022."},{"issue":"13","key":"1193_CR6","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.3390\/ijerph17134811","volume":"17","author":"E Humer","year":"2020","unstructured":"Humer E, Pieh C, Kuska M, Barke A, Doering BK, Gossmann K, et al. Provision of psychotherapy during the COVID-19 pandemic among Czech, German and Slovak psychotherapists. Int J Environ Res Public Health. 2020;17(13):4811.\u00a0 \u00a0\u00a0https:\/\/www.mdpi.com\/1660-4601\/17\/13\/4811\u00a0 Accessed 15 Apr 2022","journal-title":"Int J Environ Res Public Health"},{"key":"1193_CR7","unstructured":"Chausa P, G\u00e1rate FJ, C\u00e1ceres C, Wallitt E, Whetham J, G\u00f3mez EJ, EmERGE Consortium. EmERGE platform: a new mHealth solution for people living with HIV. In: Henriques J, Neves N, de Carvalho P, editors. XV Mediterranean Conference on Medical and Biological Engineering and Computing. MEDICON 2019. IFMBE Proceedings. Cham: Springer, vol. 76. https:\/\/link.springer.com\/chapter\/10.1007%2F978-3-030-31635-8_99. Accessed 15 Apr 2022."},{"key":"1193_CR8","doi-asserted-by":"publisher","unstructured":"Beck EJ, Mandalia S, Yfantopoulos P, Jones CI, Bremner S, Whetham J, et al., on behalf of the EmERGE Consortium. Efficiency of the EmERGE pathway to provide continuity of care for Spanish people living with medically stable HIV. Enferm Infecc Microbiol Clin. 2021:S0213-005X(20)30422-5. https:\/\/doi.org\/10.1016\/j.eimc.2020.11.018.        Accessed 15 Apr 2022","DOI":"10.1016\/j.eimc.2020.11.018"},{"key":"1193_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17843286.2021.2004697","volume":"21","author":"EJ Beck","year":"2021","unstructured":"Beck EJ, Mandalia S, Yfantopoulos P, Jones CI, Bremner S, Whetham J, et al. The efficiency of the EmERGE pathway to provide continuity of care for medically stable people living with HIV in Belgium. Acta Clin Belg. 2021 Nov;21:1\u201310. https:\/\/doi.org\/10.1080\/17843286.2021.2004697.\u00a0\u00a0Accessed 15 Apr 2022","journal-title":"Acta Clin Belg"},{"key":"1193_CR10","doi-asserted-by":"crossref","unstructured":"Beck EJ, Mandalia S, Yfantopoulos P, Jones C, Bremner S, Whetham J, et al., on behalf of the EmERGE Consortium. The cost of care for people living with stable HIV in Croatia and the efficiency of EmERGE. Croat Med J. 2021;62:562\u20136.      http:\/\/www.cmj.hr\/2021\/62\/6\/34981686.htm      Accessed 15 Apr 2022","DOI":"10.3325\/cmj.2021.62.542"},{"key":"1193_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2022.2040723","author":"EJ Beck","year":"2022","unstructured":"Beck EJ, Mandalia S, Yfantopoulos P, Jones CI, Bremner S, Fatz D, et al. The efficiency of the EmERGE Pathway of Care for people living with HIV in England. AIDS Care. 2022. https:\/\/doi.org\/10.1080\/09540121.2022.2040723.\u00a0 \u00a0Accessed 15 Apr 2022","journal-title":"AIDS Care"},{"key":"1193_CR12","unstructured":"Beck, EJ, Mandalia S, Yfantopoulos P, Jones CI, Bremner S, Whetham J, et al. The efficiency of the EmERGE platform for people living with medically stable HIV in Portugal. Porto Biomed J (in press)."},{"issue":"1","key":"1193_CR13","doi-asserted-by":"publisher","first-page":"1440782","DOI":"10.1080\/16549716.2018.1440782","volume":"11","author":"EJ Beck","year":"2018","unstructured":"Beck EJ, Shields JM, Tanna G, Henning G, de Vega I, Andrews G, et al. Developing and implementing national health identifiers in resource limited countries: why, what, who, when and how? Glob Health Action. 2018;11(1):1440782.\u00a0 \u00a0https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/16549716.2018.1440782 Accessed 15 Apr 2022","journal-title":"Glob Health Action"},{"key":"1193_CR14","doi-asserted-by":"crossref","unstructured":"Hyle EP, Naidoo K, Su AE, El-Sadr WM, Freedberg KA. HIV, Tuberculosis, and non-communicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? J Acquir Immune Defic Syndr. 2014;67(0 1):S87\u201395.   https:\/\/pubmed.ncbi.nlm.nih.gov\/25117965\/ Accessed 15 Apr 2022","DOI":"10.1097\/QAI.0000000000000254"},{"issue":"1","key":"1193_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/QAI.0000000000001014","volume":"73","author":"JL Marcus","year":"2016","unstructured":"Marcus JL, Chao CR, Leyden WA, Xu LF, Quesenberry C, Klein D, et al. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J Acquir Immune Defic Syndr. 2016;73(1):39\u201346.\u00a0 \u00a0https:\/\/insights.ovid.com\/jaids-acquired-immune-deficiency-syndromes\/jaids\/2016\/09\/010\/narrowing555\ngap-life-expectancy-hiv-infected\/6\/00126334\n556\n557 Accessed 15 Apr 2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1193_CR16","volume-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015.\u00a0\u00a0http:\/\/apps.who.int\/iris\/bitstream\/10665\/186275\/1\/9789241509565_eng.pdf?ua=1\n563\n564\u00a0 \u00a0 Accessed 15 Apr 2022"},{"issue":"11","key":"1193_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207005","volume":"13","author":"CS Autenrieth","year":"2018","unstructured":"Autenrieth CS, Beck EJ, Mallouris C, Stelzle D, Mahy M, Ghys P. Global and regional trends of people living with HIV aged 50 and over: estimates and projections for 2000\u20132020. PLoS ONE. 2018;13(11): e0207005.\u00a0 \u00a0\u00a0https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0207005\n571\n572\u00a0 Accessed 15 Apr 2022","journal-title":"PLoS ONE"},{"key":"1193_CR18","doi-asserted-by":"publisher","first-page":"32089","DOI":"10.3402\/gha.v9.32089","volume":"9","author":"EJ Beck","year":"2016","unstructured":"Beck EJ, Gill W, De Lay PR. Protecting the confidentiality and security of personal health information in low- and middle-income countries in the era of the SDGs and big-data. Glob Health Action. 2016;9:32089.\u00a0 \u00a0\u00a0https:\/\/www.tandfonline.com\/doi\/full\/10.3402\/gha.v9.32089\n580\n581\u00a0 \u00a0 Accessed 15 Apr 2022","journal-title":"Glob Health Action"},{"key":"1193_CR19","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1136\/bmj.324.7351.1434","volume":"324","author":"PS Whitten","year":"2002","unstructured":"Whitten PS, Mair FS, Haycox A, May CR, Williams TL, Hellmich S. Systematic review of cost effectiveness studies of telemedicine interventions. BMJ. 2002;324:1434\u20137.\u00a0 \u00a0https:\/\/www.bmj.com\/content\/324\/7351\/1434\u00a0 \u00a0Accessed 15 Apr 2022","journal-title":"BMJ"},{"issue":"8","key":"1193_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/1357633X0501100801","volume":"11","author":"D Hailey","year":"2005","unstructured":"Hailey D. The need for cost-effectiveness studies in telemedicine. J Telemed Telecare. 2005;11(8):379\u201383.\u00a0 \u00a0\u00a0https:\/\/doi.org\/10.1177\/1357633X0501100801\u00a0 \u00a0Accessed 15 Apr 2022","journal-title":"J Telemed Telecare"},{"key":"1193_CR21","doi-asserted-by":"crossref","unstructured":"de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012;12:CD007459.   https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007459.pub2\/abstract\n599\n600    Accessed 15 Apr 2022","DOI":"10.1002\/14651858.CD007459.pub2"},{"key":"1193_CR22","unstructured":"Public Health England. Guidance, before-and-after study: comparative studies. 2020. https:\/\/www.gov.uk\/guidance\/before-and-after-study-comparative-studies. Accessed 15 Apr 2022."},{"key":"1193_CR23","unstructured":"OECD. Purchasing power parities (PPP) 2018, Paris France. https:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm. Accessed 15 Apr 2022."},{"key":"1193_CR24","doi-asserted-by":"crossref","unstructured":"Waldrop G, Doherty M, Vitoria M, Ford N. Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy. Trop Med Int Health. 2016;1(9):1124\u201330.  https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/tmi.12746    Accessed 15 Apr 2022","DOI":"10.1111\/tmi.12746"},{"key":"1193_CR25","unstructured":"Beck EJ, Yfantopoulos P, Mandalia S. EU deliverable 3.3. costs and unit costs for EmERGE clinical sites, 29 April 2020. EU Grant Agreement No: 643736."},{"key":"1193_CR26","doi-asserted-by":"crossref","unstructured":"Le\u00f3n A, C\u00e1ceres C, Fern\u00e1ndez E, Chausa P, Martin M, Codina C, et al. New multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study. PLoS One. 201121;6(1):e14515.  https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0014515    Accessed 15 Apr 2022","DOI":"10.1371\/journal.pone.0014515"},{"key":"1193_CR27","unstructured":"UNAIDS. Manual for costing HIV facilities and services. Geneva, Switzerland, 23rd May 2011. http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/document\/2011\/20110523_manual_costing_HIV_facilities_en.pdf. Accessed 15 Apr 2022."},{"key":"1193_CR28","unstructured":"UNAIDS. Workbook for the collection of cost information on HIV facilities and services. Geneva, Switzerland, 23rd May 2011. http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/document\/2011\/20110523_workbook_cost_info_en.pdf. Accessed 15 Apr 2022."},{"key":"1193_CR29","unstructured":"Beck EJ, Mandalia S, Yfantopoulos P. EU Deliverable 3.4. Cost-efficiency of the mHealth Pathway at the five EmERGE sites. 29 April 2020. EU Grant Agreement No: 643736."},{"key":"1193_CR30","unstructured":"Central Intelligence Agency. The world factbook: country comparison GDP (purchasing power parity). Lanley, Virginia, USA. https:\/\/www.cia.gov\/the-world-factbook\/field\/real-gdp-per-capita\/country-comparison. Accessed 15 Apr 2022."},{"key":"1193_CR31","doi-asserted-by":"crossref","unstructured":"West BT, Welch KB, Galecki AT. Linear mixed models: a practical guide using statistical software. Boca Raton (FL): Chapman & Hall\/CRC; 2007.","DOI":"10.1201\/9781420010435"},{"key":"1193_CR32","unstructured":"SAS Version 9.4. Cary (NC): SAS Institute Inc.; 2014."},{"key":"1193_CR33","first-page":"2411","volume":"18","author":"EJ Beck","year":"2004","unstructured":"Beck EJ, Mandalia S, Gaudreault M, Brewer C, Zowall H, Gilmore N, et al. The cost-effectiveness of HAART, Canada 1991\u20132001. AIDS. 2004;18:2411\u20139.\u00a0 \u00a0https:\/\/journals.lww.com\/aidsonline\/pages\/articleviewer.aspx?year=2004&issue=12030&article=00008&type=Fulltext\u00a0 \u00a0 \u00a0Accessed 15 Apr 2022","journal-title":"AIDS"},{"key":"1193_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030004","volume":"3","author":"M Badri","year":"2006","unstructured":"Badri M, Maartens G, Mandalia S, Bekker L-G, Penrod JR, Platt RW, et al. Cost-effectiveness of highly active antiretroviral therapy in South Africa. Plos Med. 2006;3: e4.\u00a0\u00a0http:\/\/www.plosmedicine.org\/article\/info:doi\/10.1371\/journal.pmed.0030004\u00a0 \u00a0 \u00a0 \u00a0Accessed 15 Apr 2022","journal-title":"Plos Med"},{"key":"1193_CR35","doi-asserted-by":"crossref","unstructured":"Mandalia S, Mandalia R, Lo G, Chadborn T, Sharott P, Youle M, et al., for the NPMS-HHC Steering Group. Rising population cost for treating people living with HIV in the UK, 1997\u20132013, PLoS One. 2010;5(12):e15677.    https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0015677     Accessed 15 Apr 2022","DOI":"10.1371\/journal.pone.0015677"},{"key":"1193_CR36","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/j.1475-6773.2005.00438.x","volume":"40","author":"JH Hibbard","year":"2005","unstructured":"Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40:1918\u201330.\u00a0 \u00a0https:\/\/europepmc.org\/article\/PMC\/1361231\u00a0 \u00a0\u00a0Accessed 15 Apr 2022","journal-title":"Health Serv Res"},{"key":"1193_CR37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/QAI.0b013e318245cafe","volume":"59","author":"M Duracinsky","year":"2012","unstructured":"Duracinsky M, Herrmann SE, Berzins B, Armstrong AR, Kohli R, Le Coeur S, et al. The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV\/AIDS. J Acquir Immune Defic Syndr. 2012;59:498\u2013505.\u00a0 \u00a0\u00a0https:\/\/www.researchgate.net\/publication\/51977525_The_development_of_PROQOL708-HIV_An_international_instrument_to_assess_the_health709-related_quality_of_life_of_persons_living_with_HIVAIDS\u00a0 \u00a0 \u00a0\u00a0Accessed 15 Apr 2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1193_CR38","unstructured":"Anonymous. Societal perspective. In: Kirch W, editor. Encyclopedia of public health. Dordrecht: Springer; 2008."},{"key":"1193_CR39","unstructured":"Jones CI, Bremner S, Whetham J. EU D6.2. Report on clinical outcomes; patient empowerment and quality of life analyses; patient experience & usability. April 2020. EU Grant Agreement No: 643736."},{"key":"1193_CR40","doi-asserted-by":"crossref","unstructured":"Marent B, Henwood F; EmERGE Consortium. Platform encounters: a study of digitised patient follow-up in HIV care. Sociol Health Illn. 2021;43(5):1117\u201335.  https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1467-9566.13274    Accessed 15 Apr 2022","DOI":"10.1111\/1467-9566.13274"},{"issue":"2","key":"1193_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1377\/hlthaff.2013.0997","volume":"33","author":"JL Hall","year":"2014","unstructured":"Hall JL, McGraw D. For telehealth to succeed, privacy and security risks must be identified and addressed. Health Aff. 2014;33(2):216\u201321.\u00a0 \u00a0https:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.2013.0997\u00a0 \u00a0Accessed 15 Apr 2022","journal-title":"Health Aff"},{"key":"1193_CR42","unstructured":"UNAIDS. The privacy, confidentiality and security assessment tool: protecting personal health information. Geneva 14th February 2019. http:\/\/www.unaids.org\/en\/resources\/documents\/2019\/confidentiality_security_assessment_tool. Accessed 15 Apr 2022."},{"key":"1193_CR43","doi-asserted-by":"crossref","unstructured":"Beck EJ, Mandalia S, DongmoNguimfack B, Pinheiro E, \u2018t Hoen E, Boulet P, et al. Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries? Glob Health Action. 2019;12(1):1586317.    https:\/\/doi.org\/10.1080\/16549716.2019.1586317   Accessed 15 Apr 2022","DOI":"10.1080\/16549716.2019.1586317"},{"key":"1193_CR44","doi-asserted-by":"crossref","unstructured":"Beck EJ, Mandalia S, Sangha R, Youle M, Brettle R, Gompels M, et al., for the NPMS-HHC Steering Group. Lower healthcare costs associated with the use of a single-pill ARV regimen in the UK, 2004-2008. PloS One. 2012;7(10):e47376.   Accessed 15 Apr 2022","DOI":"10.1371\/journal.pone.0047376"},{"key":"1193_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwac006","author":"J Bor","year":"2022","unstructured":"Bor J, Kluberg SA, LaValley MP, Evans D, Hirasen K, Maskew M, et al. One pill, once a day: simplified treatment regimens and retention in HIV care. Am J Epidemiol. 2022. https:\/\/doi.org\/10.1093\/aje\/kwac006.\u00a0 \u00a0\u00a0Accessed 15 Apr 2022","journal-title":"Am J Epidemiol"},{"key":"1193_CR46","unstructured":"WHO\/International Bank for Reconstruction and Development\/The World Bank. Tracking universal health coverage: 2017 global monitoring report, 2017. https:\/\/www.who.int\/publications\/i\/item\/9789241513555. Accessed 15 Apr 2022."}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-022-01193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-022-01193-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-022-01193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T15:24:18Z","timestamp":1669130658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-022-01193-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1007\/s40273-022-01193-z","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"11 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Funding was provided by Horizon 2020 (Grant no. 643736).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approvals were obtained for each of the five clinics involved with the study, including: Institutional Review Board of the Institute of Tropical Medicine, Antwerp, Belgium; Ethics Committee of the University Hospital for Infectious Diseases, Dr. Fran Mihaljevic, Zagreb, Croatia; Comite Etico de lnvestigacion Clinica del Hospital Clinic de Barcelona, University of HC-IDIBAPS, Barcelona, Spain; Comissao de Etica para a Saude, Hospital Capuchos, Centro Hospitalar De Lisboa Central, EPE (HC-CHLC), Lisbon, Portugal; South East Coast-Brighton & Sussex Research Ethics Committee, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent was obtained from participants to participate in the Study, and their consent for the publication and\navailability of data and materials","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication and Availability of data and materials"}},{"value":"EJB, SM and PY developed the health economic aspects of the EMERGE Project in collaboration with AL, FG, LA, JB, MdFB and JW; PY, EJB, SM, AL, MJM, FG, MW, AL, IB, SZ, JB, ASC, ET, GR, MdFB, DF, JV and JW were responsible for the data collection; EJB, SM and PY were responsible for the analyses; EJB and SM were the lead authors in collaboration with PY, AL, MJM, FG, MW, LA, IB, SZ, JB, ASC, ET, GR, MdFB, DF, JV and JW, who all reviewed and commented on drafts of the paper.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}